文献速递心境障碍

rTMS作为抗抑郁药无应答者的下一步治疗:与当前抗抑郁药治疗方法的随机对照比较

rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches.
PubMed 文献 · Am J Psychiatry · 2024-08-07

这项多中心随机对照试验纳入89例对至少两种治疗试验应答不足的单相非精神病性抑郁症患者,比较rTMS与换用抗抑郁药(均联合心理治疗)的疗效。rTMS组抑郁症状减分显著大于药物组,应答率(37.5% vs. 14.6%)和缓解率(27.1% vs. 4.9%)更高,焦虑与快感缺失症状改善更明显。

要点

  • rTMS组应答率37.5%、缓解率27.1%,均高于换药组的14.6%和4.9%。
  • rTMS对焦虑和快感缺失症状的改善大于换用抗抑郁药。
  • 反刍、认知反应性和睡眠障碍的症状减分两组无差异。

核心结论

  • 在中等程度治疗抵抗的抑郁症患者样本中,rTMS在减轻抑郁症状方面比换用抗抑郁药更有效。
  • 研究结果提示,治疗选择可能由特定症状维度指导。

研究设计与样本

  • 多中心随机对照试验,纳入89例单相非精神病性抑郁症患者,对至少两种治疗试验应答不足。
  • 患者随机接受rTMS或换用抗抑郁药,两者均联合心理治疗,治疗时长8周。
  • rTMS为左侧背外侧前额叶皮层25次高频刺激;换药按荷兰治疗算法进行。
  • 主要结局为汉密尔顿抑郁量表(HAM-D)抑郁严重度变化。

主要发现

  • rTMS组抑郁症状减分显著大于药物组。
  • rTMS组应答率37.5% vs. 药物组14.6%,缓解率27.1% vs. 药物组4.9%。
  • rTMS组焦虑和快感缺失症状减分大于换用抗抑郁药组。
  • 反刍、认知反应性和睡眠障碍的症状减分两组无差异。
  • 治疗期望与HAM-D评分变化相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for depression, little is known about the comparative effectiveness of rTMS and other treatment options, such as antidepressants. In this multicenter randomized controlled trial, rTMS was compared with the next pharmacological treatment step in patients with treatment-resistant depression. METHODS: Patients with unipolar nonpsychotic depression (N=89) with an inadequate response to at least two treatment trials were randomized to treatment with rTMS or to a switch of antidepressants, both in combination with psychotherapy. Treatment duration was 8 weeks and consisted of either 25 high-frequency rTMS sessions to the left dorsolateral prefrontal cortex or a switch of antidepressant medication following the Dutch treatment algorithm. The primary outcome was change in depression severity based on the Hamilton Depression Rating Scale (HAM-D). Secondary outcomes were response and remission rates as well as change in symptom dimensions (anhedonia, anxiety, sleep, rumination, and cognitive reactivity). Finally, expectations regarding treatment were assessed. RESULTS: rTMS resulted in a significantly larger reduction in depressive symptoms than medication, which was also reflected in higher response (37.5% vs. 14.6%) and remission (27.1% vs. 4.9%) rates. A larger decrease in symptoms of anxiety and anhedonia was observed after rTMS compared with a switch in antidepressants, and no difference from the medication group was seen for symptom reductions in rumination, cognitive reactivity, and sleep disorders. Expectations regarding treatment correlated with changes in HAM-D scores. CONCLUSIONS: In a sample of patients with moderately treatment-resistant depression, rTMS was more effective in reducing depressive symptoms than a switch of antidepressant medication. In addition, the findings suggest that the choice of treatment may be guided by specific symptom dimensions.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dalhuisen I, van Oostrom I, Spijker J, et al. rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches. Am J Psychiatry. 2024. PMID: 39108161. doi:10.1176/appi.ajp.20230556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。